XORTX Therapeutics
Stock Forecast, Prediction & Price Target

XORTX Therapeutics Financial Estimates

XORTX Therapeutics Revenue Estimates

XORTX Therapeutics EBITDA Estimates

XORTX Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $171.86M
Low: $171.86M
High: $171.86M
avg. 0%
Avg: $72.48M
Low: $72.48M
High: $72.48M
avg. -57.82%
Avg: $282.98M
Low: $282.98M
High: $282.98M
avg. 290.42%
Net Income
 
% change YoY
$-1.29M
 
N/A
$-6.98M
 
-439.31%
$-2.15M
 
69.19%
Avg: $-1.89M
Low: $-1.89M
High: $-1.89M
avg. 11.91%
Avg: $-2.66M
Low: $-2.66M
High: $-2.66M
avg. -40.62%
Avg: $47.47M
Low: $47.47M
High: $47.47M
avg. 1880.00%
EBITDA
 
% change YoY
$-4.12M
 
N/A
$-10.63M
 
-157.95%
$-4.87M
 
54.19%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$1.18
 
N/A
-$4.73
 
-300.84%
-$1.08
 
77.16%
Avg: -$1.28
Low: -$1.28
High: -$1.28
avg. -18.65%
Avg: -$1.8
Low: -$1.8
High: -$1.8
avg. -40.62%
Avg: $32.08
Low: $32.08
High: $32.08
avg. 1880.00%
Operating Expenses
 
% change YoY
$2.86M
 
N/A
$9.86M
 
244.55%
$4.80M
 
-51.27%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is XORTX Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 617.09% in 2025-2027.

We have gathered data from N/A analysts. Their low estimate is -1.89M, average is -1.89M and high is -1.89M.

What is XORTX Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 77.53% in 2025-2027.

We have gathered data from N/A analysts. Their low revenue estimate is $171.86M, average is $171.86M and high is $171.86M.

What is XORTX Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 606.90% in 2025-2027.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$1.28, average is -$1.28 and high is $-1.28.